Respiratory and Psychological Impact of Elective Surgery of Congenital Lung Malformations

NCT ID: NCT06424392

Last Updated: 2025-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

434 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-19

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The absence of surgery of Congenital lung malformations (CLMs), if it avoids a stressfull event, is accompanied by a "medicalization" of the child, which will be regularly followed up in a specialized medical and surgical environment. The persistent risk of complication, albeit low, is likely to induce over-protective parental behaviours, and to be associated with a sustained family anxiety reaction. The main objective is to test the hypothesis that the absence of surgery has a significant impact on parental anxiety, measurable at 6- 9 years of age.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The knowledge of CLMs has been revolutionized by prenatal imaging and the identification of large numbers of CLMs that remain asymptomatic. France is a leader in this field, having set up the only prospective multicentre cohort currently available internationally, with follow-up starting in the prenatal period (MALFPULM). This cohort has already enabled a better description of the prenatal history and the development of an algorithm predictive of the risk of neonatal respiratory distress. The children were followed up to the age of 2 years, and 66% of them were operated on between 0 and 2 years of age. This cohort is a unique opportunity to measure the mid-term impact of this surgical decision, in terms of both medical complications and psychological consequences.

In particular, the size of the cohort makes it possible to answer with a sufficient level of evidence to the following controversies:

* What is the risk of CLM infection in the absence of surgical removal, and is this risk dependent on the CLM phenotype?
* What is the functional respiratory impact of surgical techniques (thoracoscopy or thoracotomy), depending on the age of the surgery?
* What is the prevalence of musculoskeletal complications according to surgical techniques (thoracoscopy or thoracotomy)?
* What is the burden of the medical or surgical follow-up depending on the chosen therapeutic option?
* What is the psychological impact of the surgical decision on the parents and the child? Considering the psychological impact is a major issue for this malformative condition which mainly concerns asymptomatic children, and is of great originality because it has never been evaluated. The most recent literature clearly calls for integrating issues of family well-being and parental mental health into the follow-up of children with chronic disease and/or congenital anomalies. For this reason, the investigators chose maternal anxiety as the main criterion of this study. Specifically for CLM, demonstrating the impact of the investigator's decisions on the psychological state of the parents will be a strong encouragement to integrate this dimension in care, for a better detection of these anxious and/or depressive parental reactions, and a better personalization of the transmission of decisions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Lung Malformations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

6-9 years children with their parent(s)with fetal diagnoses of CLM

6-9 years children with their parent(s) with fetal diagnoses of CLM and included in MALFPULM who have had at least one follow-up visit between 0 and 2 years of age.

General Health Questionnaire (GHQ-12)

Intervention Type OTHER

Anxiety and depression self-reported scales for both parents

State-Trait Anxiety Inventory (STAI-Y)

Intervention Type OTHER

Anxiety and depression self-reported scales for both parents

Revised Children's Manifest Anxiety Scale (RCMAS)

Intervention Type OTHER

Anxiety and depression self-reported scales for children

World Health Organization Quality of Life (WHOQOL-BREF)

Intervention Type OTHER

Quality of life self-reported scales for parents

Parental Educational Competence Self-Evaluation Questionnaire "Questionnaire d'Auto-Évaluation de la Compétence Éducative Parentale (QAECEP)"

Intervention Type OTHER

Parental Educational Competence Self-Evaluation self-reported Questionnaire for parents

Parental interview

Intervention Type OTHER

The interview will only last about ten minutes and will take place during the first call, if the parents have agreed and are sufficiently available to answer. If the parents are not available, an appointment can be made at a later date

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

General Health Questionnaire (GHQ-12)

Anxiety and depression self-reported scales for both parents

Intervention Type OTHER

State-Trait Anxiety Inventory (STAI-Y)

Anxiety and depression self-reported scales for both parents

Intervention Type OTHER

Revised Children's Manifest Anxiety Scale (RCMAS)

Anxiety and depression self-reported scales for children

Intervention Type OTHER

World Health Organization Quality of Life (WHOQOL-BREF)

Quality of life self-reported scales for parents

Intervention Type OTHER

Parental Educational Competence Self-Evaluation Questionnaire "Questionnaire d'Auto-Évaluation de la Compétence Éducative Parentale (QAECEP)"

Parental Educational Competence Self-Evaluation self-reported Questionnaire for parents

Intervention Type OTHER

Parental interview

The interview will only last about ten minutes and will take place during the first call, if the parents have agreed and are sufficiently available to answer. If the parents are not available, an appointment can be made at a later date

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Child of the MALFPULM cohort, with their parents
* At least one follow-up visit between 0 and 2 years of age (n= 414 eligible children)
* Non-opposition of the family

Exclusion Criteria

* Child with CLM, but not included in MALFPULM
* Parents who participated in MALPULM, but with prenatal fetal death, or neonatal death.
Minimum Eligible Age

6 Years

Maximum Eligible Age

9 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

URC-CIC Paris Descartes Necker Cochin

OTHER

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christophe DELACOURT

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Necker Enfants Malades

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christophe DELACOURT, MD, PhD

Role: CONTACT

+33 144494838

Margot BERLINE, Msc, MBA

Role: CONTACT

+33 144381857

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christophe DELACOURT, MD, PhD

Role: primary

01 44 49 48 38

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A00576-41

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.